Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population

American Journal of Kidney Diseases

Volumn 46, Issue 1, 2005, Pages 86-93

  Kajbaf, Sahar ^a   Veinot, John P ^a   Ha, Andrew ^a   Zimmerman, Deborah ^a  

^a NONE

Author keywords

Bone morphogenic proteins; Calcification; End stage renal disease (ESRD); Hemodialysis (HD)

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 4; C REACTIVE PROTEIN; OSTEOPONTIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; B LYMPHOCYTE ACTIVATION; CALCIFICATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HEART VALVE CALCIFICATION; HEART VALVE SURGERY; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MACROPHAGE ACTIVATION; MALE; STAINING; T LYMPHOCYTE ACTIVATION; TISSUE SECTION;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; CALCINOSIS; COMORBIDITY; ENDOTHELIAL CELLS; FEMALE; HEART VALVE DISEASES; HEART VALVES; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LIFE EXPECTANCY; LYMPHOCYTE SUBSETS; MACROPHAGES; MALE; MIDDLE AGED; OSTEOPONTIN; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SIALOGLYCOPROTEINS; SINGLE-BLIND METHOD;

EID: 20544460601     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.03.020     Document Type: Article

References (30)

1. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 suppl 3 1998 S112 S119
2. A.K. Cheung, M.J. Sarnak, G. Yan Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients Kidney Int 58 2000 353 362
3. J. Braun, M. Oldendorf, W. Moshage, R. Heidler, E. Zeitler, F.C. Luft Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients Am J Kidney Dis 27 1996 394 401
4. E.R. Maher, B. Smyth-Walsh, S. Pugh, G. Young, J.R. Curtis Aortic and mitral valve calcification in patients with end-stage renal disease Lancet 2 8564 1987 875 877
5. E. Straumann, B. Meyer, M. Misteli, A. Blumberg, H.R. Jenzer Aortic and mitral valve disease in patients with end stage renal failure on long-term hemodialysis Br Heart J 67 1992 236 239
6. S. Ribeiro, A. Ramos, A. Brandao Cardiac valve calcification in hemodialysis patients Role of calcium-phosphate metabolism Nephrol Dial Transplant 13 1998 2037 2040
7. P. Urena, M.C. Malergue, B. Goldfarb, P.H. Prieur, C. Guedon-Rapoud, M. Petrover Evolutive aortic stenosis in hemodialysis patients Analysis of risk factors Nephrologie 20 1999 217 225
8. E.R. Maher, M. Pazianas, J.R. Curtis Calcific aortic stenosis A complication of chronic uremia Nephron 47 1987 119 122
9. A. Baglin, T. Hanslik, J.N. Vaillant, J.C. Boulard, L. Moulonguet-Doleris, J. Prinseau Severe valvular heart disease in patients on chronic dialysis, a five-year multicenter French survey Ann Med Interne (Paris) 148 1997 521 526
10. M.C. Malergue, P. Urena, P. Prieur, C. Guedon-Rapoud, M. Petrover Incidence and evolution of aortic stenosis in chronic haemodialysis patients An echocardiographic and biological study of 112 patients Arch Mal Coeur 90 1997 1595 1601
11. S. Palta, A.M. Pai, K.S. Gill, R.G. Pai New insights into the progression of aortic stenosis Implications for secondary prevention Circulation 101 2000 2497 2502
12. W.S. Arnow, C. Ahn, I. Kronzon, M.E. Goldman Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons Am J Cardiol 88 2001 693 695
13. S. Ahmed, K.D. O'Neill, A.F. Hood, A.P. Evan, S.M. Moe Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells Am J Kidney Dis 37 2001 1267 1276
14. S.J. Marchais, F. Metivier, A.P. Guerin, G.M. London Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease Nephrol Dial Transplant 14 1999 2178 2183
15. A.P. Guerin, G.M. London, S.J. Marchais, F. Metivier Arterial stiffening and vascular calcifications in end-stage renal disease Nephrol Dial Transplant 15 2000 1014 1021
16. E.R. Mohler, F. Gannon, C. Reynolds, R. Zimmerman, M.G. Keane, F.S. Kaplan Bone formation and inflammation in cardiac valves Circulation 103 2001 1522 1528
17. S.M. Moe, K.D. O'Neill, D. Duan Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins Kidney Int 61 2002 638 647
18. S.S. Srivatsa, P.J. Harrity, P.B. Maercklein Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves J Clin Invest 99 1997 996 1009
19. K. Bostrom, L.L. Demer Regulatory mechanisms in vascular calcification Crit Rev Eukaryot Gene Exp 10 2000 151 158
20. D. Proudfoot, C.M. Shanahan, P.L. Weissberg Vascular calcification New insights into an old problem J Pathol 185 1998 1 3
21. M.R. Davies, K.A. Hruska Pathological mechanisms of vascular calcification in end-stage renal disease Kidney Int 60 2001 472 479
22. W.G. Goodman, J. Goldin, B.D. Kuzion Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 2000 1478 1483
23. A. Woywodt, M. Schroeder, W. Gwinner Elevated numbers of circulating endothelial cells in renal transplant recipients Transplantation 76 2003 1 4
24. J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, G.M. London Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease Hypertension 38 2001 938 942
25. J. Zimmermann, S. Herrlinger, A. Pruy, T. Metzger, C. Wanner Inflammation enhances cardiovascular risk and mortality in hemodialysis patients Kidney Int 55 1999 648 658
26. D.W. Nissen, E.M. Tuzcu, P. Schoenhagen Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 352 2005 29 38
27. S. Jono, M.D. McKee, C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 2000 e10 e17
28. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin, F.K. Port Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients A national study Am J Kidney Dis 31 1998 607 617
29. G.M. Chertow, S.K. Burke, P. Raggi Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 2002 245 252
30. P. Raggi, J. Bommer, G.M. Chertow Valvular calcification in hemodialysis patients randomized to calcium based phosphorous binders or sevelamer J Heart Valve Dis 13 2004 134 141